Glaxosmi Pharma
₹2,536
- Market Cap
- ₹43,531Cr.
- P/E Ratio
- 41.3
- P/B Ratio
- 18.93
- EPS (TTM)
- ₹61.40
- Div Yield
- 2.25%
- ROCE
- 61.4%
- ROE
- 45.6%
52W Low: ₹2,08852W High: ₹3,121
Themes:💊 Pharma & CDMO
Appears in 2 screens
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 6.0% a year over three years.
- Debt is 0.01× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Glaxosmi_Pharma — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 41.3P/E: 41.3 | P/B: 18.93Growth
ModestSales CAGR — 3Y: 6% · 1Y: 6%Profitability
High MarginROCE: 61.4% | ROE: 45.6%Key Metrics
Valuation
PEG Ratio 2.29
Price / Sales 11.01x
Price / FCF 50.0x
Book Value ₹134
Margins & returns
Operating Margin 34%
Net Margin 27.0%
Return on Assets 24.7%